AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI-Powered Imaging Probe Points to Earlier Pancreatic Cancer Detection
LSU researcher Murtaza Aslam is using AI and light-based imaging to improve pancreatic cancer detection. The work highlights a high-stakes area of oncology where earlier diagnosis could dramatically change survival odds.
AI and Light-Based Imaging Could Push Pancreatic Cancer Detection Earlier
Researchers and students are advancing AI-assisted optical approaches that aim to spot pancreatic cancer earlier, a disease that remains notoriously difficult to catch before it spreads. The work reflects a broader shift toward combining machine learning with novel sensing methods rather than relying on imaging alone.
Rice Researchers Push AI Imaging Toward Earlier, Less Invasive Cancer Detection
Rice University researchers are advancing an AI-powered imaging probe designed to identify hallmarks of cancer with greater precision. The work reflects a broader shift in oncology toward earlier detection tools that can potentially reduce reliance on invasive procedures and improve treatment timing.
FDA greenlights Rivanna’s AI musculoskeletal imaging system as specialty AI keeps broadening
Rivanna has received FDA clearance for an AI musculoskeletal imaging system, another sign that regulatory acceptance of AI is expanding beyond the most crowded radiology use cases. The approval highlights how point solutions can win by targeting focused clinical tasks with clear workflows and measurable value.
AI-Assisted Mammograms and Cross-Border Screening Point to a Bigger Shift in Breast Imaging
Several breast imaging stories this week point to AI moving from abstract promise into practical screening workflows. From AI-assisted mammograms in Arizona to cross-border screening and commercial deployments in Brazil and India, the technology is starting to be shaped by access as much as accuracy.
Butterfly’s Next Earnings Call Will Test Whether FDA AI Clearances Are Turning Into Real Revenue
Butterfly Network’s AI tool clearance has put investor attention back on the company ahead of earnings. The bigger question is whether regulatory success in point-of-care imaging can translate into durable commercial traction.
AI model claims to outperform radiologists in spotting early pancreatic cancer
Radiology Business reports that an AI model outperformed radiologists in detecting early signs of pancreatic cancer, adding another data point to the fast-moving debate over machine performance in oncology imaging. The claim is important because it challenges a domain where specialist expertise has long been considered the benchmark.
Next-Gen Coronary Imaging Platform Wins FDA and CE Clearance, Expanding AI’s Role in Cardiology
A new AI-powered coronary imaging platform has secured both FDA clearance and a CE Mark, giving it access to major U.S. and European markets. The approval adds to the steady stream of AI imaging clearances, but also raises the bar for demonstrating clinical utility beyond technical performance.
Abbott’s Ultreon 3.0 Clearance Shows Cardiology AI Is Entering Its Productization Phase
Abbott has secured FDA clearance and CE Mark for Ultreon 3.0, its next-generation AI-powered coronary imaging platform. The milestone signals that cardiovascular AI is moving from promising software capability to regulated, commercially scaled infrastructure inside cath labs.
AI algorithm shows promise in early pancreatic cancer detection
A new study highlighted by AuntMinnie reports that an AI algorithm performed well at spotting early pancreatic cancer. The finding adds to a growing body of research suggesting imaging AI may help identify hard-to-detect cancers before symptoms emerge.
Abbott Wins FDA and EU Clearance for Ultreon 3.0, Strengthening AI Imaging Momentum
Abbott has secured both FDA and EU clearance for Ultreon 3.0, its AI-powered coronary imaging platform. The dual approvals strengthen Abbott’s position in a fast-moving market where AI is becoming a core feature of diagnostic and interventional tools.
Covera Health and Medmo Fuse Imaging AI With Care Coordination in Nationwide Platform
Covera Health and Medmo are combining diagnostic imaging AI with care coordination, creating a platform that aims to manage more than image interpretation alone. The deal highlights a growing realization that imaging value depends on what happens before and after the scan, not just inside the reading room.
The European Commission Is Funding AI Imaging Pilots, and Europe Wants Faster Proof
The European Commission has opened a call for AI medical imaging pilots, signaling a policy push to translate AI interest into practical demonstrations. The initiative suggests regulators and public funders want more real-world evidence, not just more software.
Philips Wins FDA Nod for a New AI-Powered Spectral CT Platform
Philips has secured FDA clearance for Verida, its detector-based spectral CT system that pairs advanced imaging hardware with AI-driven reconstruction and workflow support. The clearance adds momentum to a fast-developing imaging category where vendors are increasingly bundling AI into the scanner itself rather than treating it as a separate add-on.
Philips’ FDA Nod for Spectral CT Shows AI Is Becoming a Hardware Differentiator
Philips has won FDA clearance for AI-powered, detector-based spectral CT technology. The approval reinforces a bigger trend in medical imaging: AI is increasingly being bundled into core device performance rather than sold as a standalone add-on.
Mammography AI Moves Closer to Standard of Care, But FDA Has Yet to Catch Up
A new review of the MASAI trial argues that AI-augmented mammography may already be functionally standard in some screening settings, even if U.S. regulators have not fully formalized that view. The disconnect highlights a growing problem in healthcare: evidence can move faster than policy.
Breast Imaging AI Moves Into the Guideline Era as Clairity Breast Gets NCCN Recognition
Clairity Breast's addition to NCCN guidelines marks an important milestone for AI-based breast cancer risk assessment, signaling that artificial intelligence is beginning to influence standard screening pathways rather than sitting on the experimental fringe. The move could accelerate adoption of image-based risk stratification, especially for women who might otherwise be missed by traditional approaches.
Heartflow and Cleerly Fight Turns AI Imaging Competition Into a Patent War
Cardiovascular AI is moving beyond product competition and into legal conflict, with Heartflow suing rival Cleerly over patent claims. The case suggests that the next phase of AI imaging will be shaped as much by intellectual property as by algorithmic performance.
GE HealthCare and Stanford Deepen AI Imaging Partnership, Hinting at a New R&D Model for Radiology
GE HealthCare and Stanford are expanding their AI imaging collaboration, a sign that the next phase of radiology AI may be built through closer ties between industry and academic medicine. The partnership suggests vendors are looking beyond one-off algorithms toward longer-term product pipelines.
FDA Grants De Novo Clearance to First-in-Class AI MRI Aid for Parkinsonian Syndromes
Neuropacs has won De Novo classification from the FDA for an AI-based MRI diagnostic aid designed to help identify Parkinsonian syndromes. The clearance gives the product a new regulatory category and signals that imaging AI is moving deeper into neurology.
GE HealthCare’s photon-counting CT clearance raises the stakes for AI-ready imaging platforms
GE HealthCare’s claimed FDA clearance for photon-counting CT is significant not just for scanner competition, but for the next generation of AI-enabled imaging. Higher-fidelity acquisition could improve downstream algorithms, shifting value from standalone software toward integrated hardware-data-software stacks.
GE HealthCare’s FDA Nod for Photon-Counting CT Signals a New Imaging Upgrade Cycle
GE HealthCare has won FDA clearance for a photon-counting CT system, bringing one of imaging’s most anticipated hardware advances further into the clinical mainstream. The approval matters not only for image quality, but for how next-generation scanners may amplify AI, quantitative imaging, and precision diagnostics.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.